Nintib 150mg Capsule is a targeted therapy medication used in the treatment of certain types of cancer. Its active ingredient, Nintedanib, is a tyrosine kinase inhibitor. It works by blocking the activity of specific enzymes that are involved in the growth and spread of cancer cells. By inhibiting these pathways, Nintedanib helps to slow down or stop the progression of the disease.
Nintib 150mg Capsule is primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), a chronic and progressive lung disease characterized by scarring of lung tissue. It is also used in combination with docetaxel for the treatment of advanced non-small cell lung cancer (NSCLC) of the adenocarcinoma type, after first-line chemotherapy. The typical dosage is 150mg twice daily for IPF, and 150mg twice daily for NSCLC, taken with food. However, dosage may be adjusted by a healthcare professional based on individual response and tolerance.
Common side effects may include diarrhea, nausea, vomiting, abdominal pain, decreased appetite, and elevated liver enzymes. Serious side effects can occur, and patients should report any unusual symptoms to their doctor immediately. Nintib 150mg Capsule should be stored at room temperature, away from moisture and heat. It is crucial to take this medication exactly as prescribed by your doctor and to avoid grapefruit or grapefruit juice while undergoing treatment, as it can interfere with the drug’s effectiveness.
